- KSHV-encoded vIL-6 collaborates with deregulated c-Myc to drive plasmablastic
- Here, we took advantage of the laboratory mouse to enhance our understanding of KSHV-dependent pathophysiology in the B-lymphocyte lineage. .... Presented to the left is a photograph of a tumor-bearing mouse containing ~4 ml of hemorrhagic ascites.
- Understanding Acute-on-Chronic Liver Failure
- Patients who develop cirrhosis may remain asymptomatic during the early stages of advanced disease (compensated cirrhosis), with no clinical evidence of ascites, esophagogastric varices, or overt encephalopathy. As disease progression reduces hepatic ...
- FDA Grants Fast Track Designation for NAFLD and NASH Combination Therapy
- NASHVILLE, Tenn.–(BUSINESS WIRE)–NuSirt Biopharma today announced the U.S.
- Mistaken identity
- The exact pathophysiology of this ascites remains unclear. Proposed mechanisms for formation include direct tumour secretion, direct pressure on lymphatics or vessels, low serum protein or hormonal stimulation.
- Salix Announces FDA Approval of Xifaxan® 550 mg for the Treatment of IBS-D
- Xifaxan 550 mg was studied in over 3,000 patients and demonstrated the efficacy and safety of repeat treatment following completion of a two-week course of treatment.
Ascites Pathophysiology is described in multiple online sources, as addition to our editors' articles, see section below for printable documents, Ascites Pathophysiology books and related discussion.
Suggested News Resources
Great care has been taken to prepare the information on this page. Elements of the content come from factual and lexical knowledge databases, realmagick.com library and third-party sources. We appreciate your suggestions and comments on further improvements of the site.